166 related articles for article (PubMed ID: 7552621)
41. Bone scanning in patients with breast carcinoma. Should it be a routine examination in every stage group?
Inoue Y; Nishi T; Hirose T; Schichijo Y; Ibukuro K
Rofo; 1985 Dec; 143(6):676-8. PubMed ID: 3001860
[TBL] [Abstract][Full Text] [Related]
42. Value of preoperative bone and liver scans and alkaline phosphatase in the evaluation of breast cancer patients.
Brar HS; Sisley JF; Johnson RH
Am J Surg; 1993 Feb; 165(2):221-3; discussion 224. PubMed ID: 8427400
[TBL] [Abstract][Full Text] [Related]
43. The value of bone scanning in the staging of breast cancer.
Kirkman S; Henk JM
Clin Radiol; 1979 Jan; 30(1):11-4. PubMed ID: 421415
[TBL] [Abstract][Full Text] [Related]
44. An evaluation of radionuclide bone scanning and liver ultrasonography for staging breast cancer.
Cox MR; Gilliland R; Odling-Smee GW; Spence RA
Aust N Z J Surg; 1992 Jul; 62(7):550-5. PubMed ID: 1610323
[TBL] [Abstract][Full Text] [Related]
45. Investigation of computer-aided diagnosis system for bone scans: a retrospective analysis in 406 patients.
Tokuda O; Harada Y; Ohishi Y; Matsunaga N; Edenbrandt L
Ann Nucl Med; 2014 May; 28(4):329-39. PubMed ID: 24573796
[TBL] [Abstract][Full Text] [Related]
46. Staging breast cancer: role of bone scanning.
Davies CJ; Griffiths PA; Preston BJ; Morris AH; Elston CW; Blamey RW
Br Med J; 1977 Sep; 2(6087):603-5. PubMed ID: 901997
[TBL] [Abstract][Full Text] [Related]
47. Predictive value of excretory urography, ultrasonography, computerized tomography, and liver and bone scan in the staging of bilharzial bladder cancer in Saudi Arabia.
Hanash KA; Bissada NK; Abla A; Esmail D; Dowling A
Cancer; 1984 Jul; 54(1):172-6. PubMed ID: 6232995
[TBL] [Abstract][Full Text] [Related]
48. Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer.
Bychkovsky BL; Guo H; Sutton J; Spring L; Faig J; Dagogo-Jack I; Battelli C; Houlihan MJ; Yeh TC; Come SE; Lin NU
Oncologist; 2016 Dec; 21(12):1495-1501. PubMed ID: 27551013
[TBL] [Abstract][Full Text] [Related]
49. Selection of patients with breast cancer for routine follow-up bone scans.
Coleman RE; Fogelman I; Habibollahi F; North WR; Rubens RD
Clin Oncol (R Coll Radiol); 1990 Nov; 2(6):328-32. PubMed ID: 2278890
[TBL] [Abstract][Full Text] [Related]
50. Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective?
Wikenheiser KA; Silberstein EB
Cleve Clin J Med; 1996; 63(1):43-7. PubMed ID: 8590515
[TBL] [Abstract][Full Text] [Related]
51. The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system.
Lee JE; Park SS; Han W; Kim SW; Shin HJ; Choe KJ; Oh SK; Youn YK; Noh DY; Kim SW
Cancer; 2005 Aug; 104(3):499-503. PubMed ID: 15968691
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance and outcome of one or two rib lesions on bone scans in breast cancer patients without known metastases.
Chen HH; Su WC; Guo HR; Lee BF; Su WR; Wu PS; Chiu NT
Nucl Med Commun; 2003 Nov; 24(11):1167-74. PubMed ID: 14569171
[TBL] [Abstract][Full Text] [Related]
53. [Carcinoma of the breast: diagnosis of sub-clinical bone metastases. Predictive value of isotope bone scan (author's transl)].
Calle R; Gongora R; Vilcoq JR; Desprez P; Schlienger P
Bull Cancer; 1980; 67(3):313-7. PubMed ID: 7407429
[TBL] [Abstract][Full Text] [Related]
54. Role of bone scan in addition to CT in patients with breast cancer selected for systemic staging.
McCartan DP; Prichard RS; MacDermott RJ; Rothwell J; Geraghty J; Evoy D; Quinn CM; Skehan SJ; O'Doherty A; McDermott EW
Br J Surg; 2016 Jun; 103(7):839-44. PubMed ID: 27004443
[TBL] [Abstract][Full Text] [Related]
55. [The value of skeletal scintigraphy in the aftercare of breast carcinoma. A prospective study of 750 cases].
Schünemann H; Jourdain M
Dtsch Med Wochenschr; 1989 Jan; 114(1):3-8. PubMed ID: 2535982
[TBL] [Abstract][Full Text] [Related]
56. Is bone scanning of value in patients with breast cancer?
Spencer GR; Khan M; Bird C; Seymour R; Brown TR; Collins CD
Acta Chir Scand; 1981; 147(4):247-8. PubMed ID: 6459704
[TBL] [Abstract][Full Text] [Related]
57. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance imaging for detection of prostate cancer metastatic to bone.
Turner JW; Hawes DR; Williams RD
J Urol; 1993 Jun; 149(6):1482-4. PubMed ID: 8501793
[TBL] [Abstract][Full Text] [Related]
59. The role of whole-body bone scanning and clinical factors in detecting bone metastases in patients with non-small cell lung cancer.
Erturan S; Yaman M; Aydin G; Uzel I; Müsellim B; Kaynak K
Chest; 2005 Feb; 127(2):449-54. PubMed ID: 15705981
[TBL] [Abstract][Full Text] [Related]
60. Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
Toloza EM; Harpole L; McCrory DC
Chest; 2003 Jan; 123(1 Suppl):137S-146S. PubMed ID: 12527573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
